Navigation Links
SenesTech Scientists Attend International Workshop on Fertility in New Zealand

FLAGSTAFF, Ariz., March 4 /PRNewswire/ -- SenesTech, Inc. scientists, Drs. Loretta Mayer, Cheryl Dyer and Timothy Vail, were invited to attend the Third International Workshop on Fertility Control in Wildlife Management in Lincoln, New Zealand where they presented SenesTech's latest developments in humane animal population management. This invitation only meeting is organized by the governments of Australia, the United States, New Zealand and Great Britain, who are working together to support the development of new, more effective methods for wildlife management, and by treaty, will accept the research done in any one of the four countries. In previous years attendees have presented research on contraceptive vaccines, parasite-vectored fertility control, and oral bait delivery systems for fertility control. This invitation reflects the cutting edge nature of SenesTech's research into chemical fertility management in the rice field rat of Southeast Asia as it is the only non-governmental entity invited to the workshop during the four year history of this annual meeting.

SenesTech's initial product, ContraPest(TM), which is being developed to counteract the rice rat plague in the rice producing countries of the world, will dramatically improve rice yields in Southeast Asia by reducing the rice field rat population. Over half of the worlds 6 billion people depend on rice as their primary food source and Southeast Asia produces over 84% of this resource. Currently, 1/5-1/3 of the Southeast Asian rice crop is severely damaged by these rice field rats. SenesTech's product is a unique non-toxic, environmentally sound oral bait that can dramatically reduce this pest population, resulting in a substantial reduction in the devastation caused by rice field rats in just one growing season. A simple 10% increase in rice production as a result of population management through ContraPest(TM) will feed an additional 380 million people.

An additional SenesTech product, ChemSpay(TM) is the only product currently under development that has been shown to induce permanent sterility in female dogs. Further, SenesTech has a prototype drug delivery system that allows for a single exposure to induce sterility in dogs.

SenesTech is partnered with Dr. Lyn Hinds, the Senior Principal Research Scientist of the Commonwealth Scientific and Industrial Research Organisation (CSIRO) in Australia and Dr. Sudamaji at the Indonesian Centre for Rice Research (ICRR).

About: (SenesTech, Inc.) SenesTech is a platform technology company located in Flagstaff, Arizona, on the Northern Arizona Center for Emerging Technology campus. SenesTech specializes in humane animal population management products for companion animals and wildlife.

SOURCE SenesTech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SenesTech, Inc. Appoints Susan Airhart to Board of Directors
2. SenesTech, Inc. Commences Product Registration Process With Australian Government
3. SenesTech, Inc. Initiates Research Field Trials for ContraPest(R) in Indonesia
4. Arizona-Based SenesTech, Inc., Partners With Australia to Stop Starvation Due to Rice Shortages
5. Scientists prove graphenes edge structure affects electronic properties
6. Obama Advisor Joins Connecticut and International Scientists at New Haven Stem Cell Symposium
7. Scientists publish complete genetic blueprint of key biofuels crop
8. 2010 Japan Prize to Honor Scientists and Researchers in Industrial Production/Production Technology and Biological Production/Environment Fields
9. BOXX Personal Supercomputer for Research Scientists Featured at SC08
10. NanoBio to Give Four Scientific Presentations at Upcoming National Meeting of Pharmaceutical Scientists
11. Scientists restore movement to paralyzed limbs through artificial brain-muscle connections
Post Your Comments:
(Date:11/24/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... quarter ended September 30, 2015. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of iCo ... value enriching for this clinical program, but also ...
(Date:11/24/2015)... , Nov. 24, 2015  Clintrax Global, Inc., a worldwide provider ... , today announced that the company has set a new ... 391% quarter on quarter growth posted for Q3 of 2014 to ... and Mexico , with the establishment of an ... 2015. --> United Kingdom and ...
(Date:11/24/2015)... SHPG ) announced today that Jeff Poulton , ... Annual Healthcare Conference in New York City ... (1:30 p.m. GMT). --> SHPG ) announced today that ... Piper Jaffray 27 th Annual Healthcare Conference in ... at 8:30 a.m. EST (1:30 p.m. GMT). --> Shire ...
(Date:11/24/2015)... SAN FRANCISCO , Nov. 24, 2015 /PRNewswire/ ... today announced that Emily Leproust, Ph.D., Twist Bioscience ... Piper Jaffray Healthcare Conference on December 1, 2015 ... Palace Hotel in New York City. ... . Twist Bioscience is on ...
Breaking Biology Technology:
(Date:11/19/2015)... , Nov. 19, 2015  Although some 350 ... is dominated by a few companies, according to Kalorama ... own 51% of the market share of the 6.1 ... The World Market for Molecular Diagnostic s . ... "The market is still controlled by one company and ...
(Date:11/17/2015)... 2015  Vigilant Solutions announces today that Mr. ... Directors. --> --> ... the partnership at TPG Capital, one of the largest ... Billion in revenue.  He founded and led TPG,s Operating ... companies, from 1997 to 2013.  In his first role, ...
(Date:11/12/2015)...   Growing need for low-cost, easy to ... paving the way for use of biochemical sensors ... in clinical, agricultural, environmental, food and defense applications. ... medical applications, however, their adoption is increasing in ... emphasis on improving product quality and growing need ...
Breaking Biology News(10 mins):